A phase I trial of AF 219.
Phase of Trial: Phase I
Latest Information Update: 23 Dec 2009
At a glance
- Drugs Gefapixant (Primary)
- Indications Pain
- Focus Adverse reactions; Therapeutic Use
- Sponsors Afferent Pharmaceuticals
- 23 Dec 2009 New trial record
- 17 Dec 2009 According to an Afferent Pharmaceuticals media release this phase I trial of AF 219 is complete.